Apranax | Analytical Method Development | Validation | BA/BE Studies

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Apranax
BioAnalytical Methods

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Arlanda is your partner for the Brazil market.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Apranax

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 23 USDMF, 12 CEP/COS, 1 JDMF, 3 EU WC, 37 KDMF, 12 NDC API, 1 VMF, 19 Listed Suppliers, $ API Reference Price

42 API Suppliers
23 USDMF
12 CEP/COS
1 JDMF
3 EU WC
37 KDMF
12 NDC API
1 VMF
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

333 FDF Dossiers, 115 FDA Orange Book, 96 Europe, 25 Canada, 23 Australia, 24 South Africa, 50 Listed Dossiers

333 FDF Dossiers
115 FDA Orange Book
96 Europe
25 Canada
23 Australia
24 South Africa
50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 375MG, TABLET;ORAL - 500MG, SUSPENSION;ORAL - 25MG/ML, TABLET, DELAYED RELEASE;ORAL - 375MG, TABLET, DELAYED RELEASE;ORAL - 500MG, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG
TABLET;ORAL - 375MG
TABLET;ORAL - 500MG
SUSPENSION;ORAL - 25MG/ML
TABLET, DELAYED RELEASE;ORAL - 375MG
TABLET, DELAYED RELEASE;ORAL - 500MG
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

7 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 6 DKSH, 6 Faran Shimi Pharmaceutical, 11 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 33 BASF, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Coating Systems & Additives, 70 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 38 Disintegrants & Superdisintegrants, 35 Solubilizers, 31 Thickeners and Stabilizers, 29 Direct Compression, 27 Granulation, 24 Film Formers & Plasticizers, 20 Taste Masking, 17 Co-Processed Excipients, 17 Lubricants & Glidants, 16 Topical, 15 Parenteral, 11 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

72 Coating Systems & Additives
70 Fillers, Diluents & Binders
41 Controlled & Modified Release
38 Disintegrants & Superdisintegrants
35 Solubilizers
31 Thickeners and Stabilizers
29 Direct Compression
27 Granulation
24 Film Formers & Plasticizers
20 Taste Masking
17 Co-Processed Excipients
17 Lubricants & Glidants
16 Topical
15 Parenteral
11 Chewable & Orodispersible Aids
8 Emulsifying Agents
7 Rheology Modifiers
6 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

35 News #PharmaBuzz

35 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 83 Regulatory FDF Prices, 1 Annual Reports

1 US Medicaid Prescriptions
83 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

33 APIs, 3 FDF Dossiers

33 APIs
3 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 14 Others

3 EDQM
5 USP
14 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 37 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1ICBio Clinical Research Pvt Ltd

02 2QUINTA-ANALYTICA s.r.o

filter Analyte Reset all filters

3 All

01 3Naproxen

filter Method Reset all filters

3 All

01 2HPLC/MS/MS

02 1LSMS/MS

filter Units Reset all filters

3 All

01 1ng/mL

02 2ng/ml

filter Details Reset all filters

3 All

01 1Human Plasma

02 1in urine

03 1Blank

Product Main Page

01

ICBio Clinical Research Pvt Ltd

DCAT Week

Not Confirmed

ICBio Clinical Research Pvt Ltd

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Analyte : Naproxen

Method : LSMS/MS

LLOQ : 0.5

Units : ng/mL

Details : Human Plasma

Portfolio PDF

Product Web Link

Digital Content

02

QUINTA-ANALYTICA s.r.o

DCAT Week

Not Confirmed

QUINTA-ANALYTICA s.r.o

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Analyte : Naproxen

Method : HPLC/MS/MS

LLOQ : 200

Units : ng/ml

Details :

Portfolio PDF

Product Web Link

Digital Content

03

QUINTA-ANALYTICA s.r.o

DCAT Week

Not Confirmed

QUINTA-ANALYTICA s.r.o

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Analyte : Naproxen

Method : HPLC/MS/MS

LLOQ : 10

Units : ng/ml

Details : in urine

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!